Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Sympathetic ophthalmia is a rare, bilateral inflammatory eye disease that can occur after a penetrating injury or intraocular surgery. The immune system reacts to exposed eye tissues and can inflame both eyes, including the eye that was not injured. It typically presents as granulomatous uveitis and can involve the retina and choroid. Rapid diagnosis and systemic treatment can reduce permanent vision loss risk.
read more about sympathetic ophthalmia ...Sympathetic ophthalmia begins after ocular trauma or surgery disrupts normal barriers and exposes immune-privileged eye antigens. The immune response can then target similar tissues in both eyes, leading to widespread inflammation. Penetrating injury is a classic trigger, but the condition can also follow procedures such as vitrectomy. Onset can occur weeks to months later, though timing can vary widely. Risk is low overall, but any new uveitis symptoms after eye injury or surgery should raise concern.
Symptoms often include blurred vision, light sensitivity, redness, and aching eye pain in one or both eyes. Floaters can appear when inflammatory cells spill into the vitreous. Some people notice reduced contrast and a general haze that worsens over days to weeks. Vision loss can progress if inflammation reaches the retina, choroid, or optic nerve. New symptoms after eye trauma or surgery should be evaluated promptly because early treatment can limit tissue damage.
Diagnosis is based on clinical exam plus a history of prior eye injury or intraocular surgery. A slit-lamp and dilated exam look for granulomatous uveitis signs, such as mutton-fat keratic precipitates and posterior segment inflammation. OCT and fluorescein angiography can document retinal and choroidal involvement and help track response to therapy. Other causes of bilateral uveitis, such as Vogt-Koyanagi-Harada disease and infections, are considered and ruled out based on exam and testing. Close follow-up is used because activity can change quickly during early treatment.
Treatment usually starts with high-dose systemic corticosteroids to rapidly calm inflammation. Many cases then need steroid-sparing immunosuppressive therapy, such as methotrexate, azathioprine, mycophenolate, cyclosporine, or biologics, guided by a uveitis specialist. Topical drops can support comfort and anterior inflammation control, but systemic therapy is often needed for posterior involvement. In rare situations with a severely injured eye that has no visual potential, early removal of the injured eye may be discussed, though modern medical therapy often becomes the main approach. Long-term monitoring is common because relapse can occur when medicine is tapered too quickly.
Yes, though it is rare. It can follow intraocular surgery, including vitrectomy, especially when inflammation develops after a procedure. New uveitis symptoms after surgery should be evaluated promptly.
It often starts weeks to months after injury, but earlier or later onset can happen. The timing depends on the immune response and the degree of tissue disruption. Any new inflammation after trauma still warrants evaluation, regardless of timing.
Yes. Even though only one eye is injured, inflammation can develop in both eyes, including the uninjured eye. That bilateral pattern is part of what makes the condition serious. Prompt systemic treatment can protect the fellow eye.
Sympathetic Ophthalmia. EyeWiki. https://eyewiki.org/Sympathetic_Ophthalmia. Date Accessed: February 4, 2026.
Sympathetic Ophthalmia. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK589651/. Date Accessed: February 4, 2026.
Sympathetic Ophthalmia - Eye Disorders. MSD Manual Professional Edition. https://www.msdmanuals.com/professional/eye-disorders/uveitis-and-related-disorders/sympathetic-ophthalmia. Date Accessed: February 4, 2026.
Sympathetic Ophthalmia: An Overview. PubMed. https://pubmed.ncbi.nlm.nih.gov/35579612/. Date Accessed: February 4, 2026.
Sympathetic Ophthalmia. Merck Manual Consumer Version. https://www.merckmanuals.com/home/eye-disorders/uveitis-and-related-disorders/sympathetic-ophthalmia. Date Accessed: February 4, 2026.